Requires health insurance coverage for prosthetic and orthotic devices that equals the coverage and payment provided for by federal laws and regulations for the aged and disabled.
This bill would require most New York health insurance policies, group and blanket policies, and health maintenance organizations to cover prosthetic and orthotic devices at a level that matches federal Medicare-related coverage for the aged and disabled. The bill specifically requires payment at no less than the current quarter’s Medicare DMEPOS fee schedule and expands coverage to include the most appropriate device model determined by the enrollee’s health care provider, including devices needed for physical activity, bathing or showering, and devices that support whole-body health and limb function.
The bill also requires coverage for necessary materials, components, instruction on device use, and medically necessary repair or replacement in specified circumstances. It prohibits insurers from imposing separate financial requirements unique to prosthetic and orthotic coverage, limits cost-sharing to no more restrictive than inpatient physician and surgical services, and bars denial of benefits to people with limb loss or absence when a comparable service would be covered for a non-disabled person. It further directs managed care plans to ensure access to prosthetic and orthotic providers, including out-of-network referral and reimbursement when needed, and requires utilization review to be nondiscriminatory.
In addition to insurance coverage mandates, the bill amends reporting requirements so insurers and health plans must report claims data related to these prosthetic and orthotic services. Those reports would be public and could be used to evaluate denials and payment patterns. The bill takes effect January 1, 2027 and applies to policies and contracts issued, renewed, modified, altered, or amended on or after that date.
The overall sentiment reflected by the bill text is strongly supportive of expanded access and anti-discrimination protections for people who use prostheses and orthoses. Because there are no committee transcripts or votes provided, there is no recorded public debate in the supplied materials, but the structure of the bill indicates a policy goal of improving coverage parity, mobility, and functional independence for people with limb loss or other medical needs.
The main points of contention likely concern cost and utilization: insurers may object to the broader coverage mandate, the requirement to cover more than one device model or specialty use case, the limits on cost-sharing, and the open-ended replacement provisions. Managed care plans and utilization review entities may also resist the network-access and nondiscrimination requirements, while advocates for people with disabilities would likely support the bill’s expanded access and parity provisions.
The bill would amend the insurance law, social services law, and public health law to create a statewide coverage mandate for prosthetic and orthotic devices across individual, group, blanket, and HMO coverage. It would also require managed care access standards, prohibit discriminatory utilization review, and expand insurer reporting obligations regarding claims and denials tied to prosthetic and orthotic services. Affected parties include insurers, HMOs, managed care providers, prosthetists/orthotists, and enrollees with limb loss or other medical needs requiring these devices.
The bill’s policy direction is clearly favorable to consumers and disability access, emphasizing parity, medical necessity, and nondiscrimination. No votes or transcript excerpts were provided, so there is no documented committee or floor sentiment to summarize beyond the bill’s text. Based on the provisions, the likely support comes from disability advocates and affected patients, while likely opposition would come from insurers and managed care organizations concerned about mandated benefits and reimbursement costs.
The most likely areas of disagreement are the scope of required coverage, especially the mandate to cover the most appropriate device model for exercise, bathing, and other functional activities; the requirement to pay at Medicare-linked rates; the prohibition on more restrictive cost-sharing; and the replacement rules that limit lifetime-use restrictions. Insurers and managed care plans may also contest the requirement to maintain access to at least two in-network prosthetic/orthotic providers and to fully reimburse out-of-network providers when in-network services are unavailable. Disability advocates and patients are likely to support these provisions as necessary to ensure meaningful access and equal treatment.